Evernorth Launches Pharmacy Forward: A Simpler, Faster Specialty Pharmacy Experience for Patients Managing Complex Conditions

Evernorth, the health services division of The Cigna Group (NYSE:CI), launched Pharmacy Forward, an AI-powered specialty pharmacy program initially at Accredo.

Rhea-AI Summary

Evernorth, the health services division of The Cigna Group (NYSE:CI), launched Pharmacy Forward, an AI-powered specialty pharmacy program initially at Accredo. Supported by a $100 million investment through 2028, it applies AI to clinical care, prescription intake, administration, and fulfillment to speed access and personalize support.

The program aims to cut prescription-to-medication time in half, keep adherence above 80%, reduce clinician documentation time by up to 50%, increase digital pathway use by 25%, and place 90% of patients within one-day or same-day shipping. Evernorth expects about $400 million in value by 2028.

Positive

• AI-enabled specialty pharmacy program backed by $100 million investment through 2028
• Time from prescription to medication reportedly cut by 50%
• Clinician documentation time expected to decline by up to 50%
• Digital pathway use anticipated to rise by 25%
• Shipping network designed to place 90% of patients within 1-day or same-day radius
• Program expected to generate about $400 million in value by end of 2028

Negative

• None.

Argus Jul 1 session

+0.50% close to close Open Argus

Details

News Market Reaction – CI

On Jul 1, the day this news came out, CI closed 0.50% above the previous close.

Data tracked by StockTitan Argus for the Jul 1 session.

Key Figures

Program investment: $100 million Adherence benchmark: 80% Documentation reduction: 50% +5 more

Program investment

$100 million

Funding for Pharmacy Forward through 2028

Adherence benchmark

80%

Industry standard medication adherence rate referenced for improvement

Documentation reduction

50%

Expected decrease in clinician documentation time via AI

Digital pathway increase

25%

Anticipated rise in use of personalized patient digital pathways

Shipping coverage

90%

Patients within 1-day or same-day ground shipping radius

Care facilities

nearly 40

Accredo care facilities expanding capacity and capabilities

Program value

$400 million

Expected value generated by Pharmacy Forward by end of 2028

Patients served

more than 1,000,000 patients

Accredo patients served each year

Historical Context

5 past events · Latest: Jun 25

5 events

1. Jun 25

   Charitable grant program

   24h Move

   +0.9%

   Multi‑year grant honoring leadership to support military and veteran communities.

2. Jun 23

   Youth mental health grants

   24h Move

   +0.3%

   Foundation commits multimillion‑dollar grants to strengthen youth mental health services.

3. Jun 02

   Veteran support grants

   24h Move

   -0.5%

   Launch of 2026 grant cycle focused on improving veteran mental health support.

4. May 13

   Conference appearance

   24h Move

   +0.7%

   Executive presentation at a major health care conference with webcast to investors.

5. Apr 30

   Earnings and outlook

   24h Move

   -0.6%

   Strong Q1 results and raised 2026 outlook driven by Evernorth and margin gains.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

therapeutic resource centers, predictive analytics, prior authorization, copay assistance, +1 more

5 terms

therapeutic resource centers medical

"Accredo Specialty Pharmacy – which serves patients ... through condition-specific Therapeutic Resource Centers (TRCs)"

Therapeutic resource centers are physical or virtual hubs that coordinate medical treatments, patient education, and support services for people receiving specific therapies. They act like a travel center for a complicated trip—organizing appointments, medication access, training and follow‑up so patients and clinicians can navigate care more smoothly; investors care because these centers can affect treatment uptake, patient outcomes, revenue flow and the efficiency of delivering a therapy to market.

predictive analytics technical

"By integrating clinical data and insights, AI-generated summaries, and predictive analytics, care teams can deliver"

Predictive analytics uses historical data and patterns to estimate future outcomes, like sales, customer behavior, or operational problems. For investors it matters because it turns past signals into probable forecasts—similar to a weather forecast or traffic app—helping assess potential risks, spot opportunities, and prioritize where to allocate capital, while remembering that predictions carry uncertainty and are not guarantees.

prior authorization regulatory

"By using AI to improve the completeness of prior authorization submissions, identify copay assistance eligibility"

Prior authorization is a process where a health insurance company requires approval before covering certain medical services or medications. It functions like a pre-approval step, ensuring that the treatment is necessary and appropriate before expenses are paid. For investors, understanding prior authorization is important because delays or denials can impact healthcare costs, provider operations, and the financial stability of related companies.

copay assistance financial

"improve the completeness of prior authorization submissions, identify copay assistance eligibility, and ensure prescriptions"

Copay assistance are programs—often run by drugmakers or patient charities—that lower the out‑of‑pocket cost a patient pays for a prescription, functioning like a coupon, voucher or temporary rebate at the pharmacy. Investors care because these programs can raise demand and adherence for otherwise expensive medicines, obscure the actual net price paid by payers, and create regulatory or reimbursement risks that affect sales forecasts and revenue predictability.

specialty pharmacy medical

"A Smarter, Faster, More Personalized Specialty Pharmacy ExperiencePharmacy Forward applies AI across four core areas"

A specialty pharmacy is a pharmacy that focuses on dispensing and managing high-cost, complex medications that often need special storage, handling, administration or ongoing patient monitoring—think of it as a concierge service for drugs that require extra care. Investors pay attention because these pharmacies control access, support adherence and billing for expensive treatments, which affects drug sales, reimbursement, margins and long-term revenue predictability for manufacturers and payers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

New program introduces AI-enabled capabilities to personalize support, streamline prescription processing, and help patients start and stay on therapy with greater ease and confidence

BLOOMFIELD, Conn., July 1, 2026 /PRNewswire/ -- As specialty care becomes more complex, patients need faster, more connected, and personalized support. To help meet that need, Evernorth, the health services division of The Cigna Group (NYSE:CI), today unveiled Pharmacy Forward, a new AI-powered program designed to improve how patients access and experience specialty care. Launching first with Accredo Specialty Pharmacy – which serves patients with chronic and complex specialty conditions through condition-specific Therapeutic Resource Centers (TRCs) – the program is supported by a $100 million investment through 2028. This investment enables care teams to focus more on clinical care and patient outcomes while reducing prescription processing timelines and improving service responsiveness.

"Patients navigating complex health conditions need comprehensive, expert support, often during some of the most difficult moments in their lives," said Matt Perlberg, President of the Evernorth Health Services pharmacy and care delivery businesses, including Accredo, and Executive Vice President of Customer Innovation for The Cigna Group.  "Pharmacy Forward reflects our commitment to meet patients where they are —delivering an even faster, more seamless experience while ensuring they receive the personalized support and clinical care they deserve."

A Smarter, Faster, More Personalized Specialty Pharmacy Experience
Pharmacy Forward applies AI across four core areas: clinical care, prescription intake, administration, and medication fulfillment:

1. Care Enablement — Supporting More Coordinated, Insight-Driven Care: Pharmacy Forward is expected to improve medication adherence beyond the industry standard of 80%, helping patients stay on therapy and achieve optimal health outcomes. By integrating clinical data and insights, AI-generated summaries, and predictive analytics, care teams can deliver more connected, informed support. This enables clinicians to proactively identify patients at risk of falling off therapy or experiencing adverse events, empowering earlier intervention, stronger coordination, and an improved patient experience. The program uses AI to free up more time for clinicians to focus on patient care and is expected to reduce clinician documentation time by up to 50%.
   
   
2. Experience Accelerators – Improving the Patient Journey in Real Time: Pharmacy Forward uses AI-enabled tools to reach patients earlier in their care journey and deliver more proactive, personalized support. For example, Accredo has implemented AI-enabled scheduling so outreach occurs during patients' preferred call windows. Additionally, Accredo anticipates a 25% increase in use of personalized patient digital pathways, enabling more patients to complete routine steps on their own terms — getting answers faster, starting prescriptions through the app or website, and scheduling therapy more easily.
   
   
3. Rx Readiness — Accelerating Time to Therapy: Pharmacy Forward is cutting the time it takes for patients to receive their medication after Accredo receives a prescription in half — helping patients start treatment sooner. By using AI to improve the completeness of prior authorization submissions, identify copay assistance eligibility, and ensure prescriptions are ready earlier in the process, the program is designed to streamline the time it takes to process a prescription and reduce delays in care.
   
   
4. One Fulfillment Network — Delivering Medications Faster and More Reliably: Pharmacy Forward will enhance Accredo's ability to ship complex specialty medications from sites as close to a patient's home as possible, ensuring that 90% of patients are within a 1-day or same day ground shipping radius. To enable this, Accredo is expanding capacity, staffing, and capabilities at many of its nearly 40 care facilities to reduce the need for longer ground or air shipments, which are more susceptible to delays from adverse events such as weather. The enhancements will be supported by AI technology, for example, to continuously analyze factors such as patient location, delivery timing, and medication handling requirements to determine the most effective dispensing location.

Together, these capabilities represent the next evolution of specialty pharmacy — combining AI, clinical expertise, and operational scale to create a more connected and responsive care experience. The program is expected to generate approximately $400 million in value by the end of 2028, helping make care more coordinated and personalized for the more than one million patients Accredo serves each year. Evernorth expects to extend many of these capabilities to its other pharmacies' operations in the coming years.

"AI is enabling us to fundamentally reimagine how we support each patient's journey," said Katya Andresen, Chief Data, Digital and AI Officer, The Cigna Group. "By responsibly combining real-time data, advanced analytics and deep clinical expertise, we can deliver more personalized, proactive support — helping people access the care they need faster and achieve better health outcomes."

About Evernorth Health Services
Evernorth Health Services is the pharmacy, care, and benefits solutions division of The Cigna Group (NYSE: CI). We create and deliver innovative, flexible, and people-first solutions that solve the most complex health care challenges. Evernorth is home to pioneering brands including Express Scripts, Express Scripts Pharmacy, Accredo, eviCore, and MD Live. We have more than 40,000 employees who work to make health care more affordable, predictable, and simple for the 190 million people we serve. Learn more at evernorth.com.

Media Contact
Justine Sessions
Justine.sessions@evernorth.com
860-810-6523 

View original content to download multimedia:https://www.prnewswire.com/news-releases/evernorth-launches-pharmacy-forward-a-simpler-faster-specialty-pharmacy-experience-for-patients-managing-complex-conditions-302815277.html

SOURCE Evernorth

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is Evernorth's Pharmacy Forward program for Accredo patients (NYSE:CI)?

Pharmacy Forward is an AI-powered specialty pharmacy program aimed at simplifying and speeding care for Accredo patients. According to Evernorth, it supports clinical care, intake, administration, and fulfillment to personalize support and help patients start and stay on complex therapies.

How much is Evernorth investing in Pharmacy Forward and over what timeline (CI stock)?

Evernorth plans to invest $100 million in Pharmacy Forward through 2028. According to The Cigna Group, this funding supports AI capabilities that streamline prescription processing, enhance care-team efficiency, and improve responsiveness across Accredo’s specialty pharmacy network.

How will Pharmacy Forward affect time to therapy for Accredo specialty patients (NYSE:CI)?

Pharmacy Forward is described as cutting the time from prescription receipt to medication delivery in half. According to Evernorth, AI improves prior authorization completeness, copay assistance identification, and prescription readiness, aiming to reduce delays and help patients start treatment sooner.

What shipping improvements does Pharmacy Forward bring to Accredo's specialty pharmacy network?

Pharmacy Forward aims to ensure 90% of patients are within a one-day or same-day ground shipping radius. According to Evernorth, Accredo is expanding capacity and using AI to select optimal dispensing sites, targeting faster, more reliable delivery of complex specialty medications.

What financial value does Evernorth expect Pharmacy Forward to create by 2028 (CI)?

Evernorth expects Pharmacy Forward to generate approximately $400 million in value by the end of 2028. According to The Cigna Group, this value comes alongside more coordinated, personalized care for over one million patients served annually by Accredo.

How does Pharmacy Forward use AI to support clinicians and patients managing complex conditions?

Pharmacy Forward uses AI for data integration, predictive analytics, and documentation support to aid clinicians and patients. According to Evernorth, it may cut clinician documentation time by up to 50% and help identify patients at risk of non-adherence or adverse events.